CRM vs REGN · P/E 41, rev $11.35B vs P/E 14, rev $4.29B
Salesforce.com Inc (CRM) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Salesforce.com Inc (CRM) is a software - application company listed on US. It is led by Marc Benioff.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported CRM revenue for 2026-07-31 was $11.35B. Net income was $3.53B. Revenue was up 1.9% from 2026-04-30 to 2026-07-31. CRM currently screens at market cap $252.36B and trailing P/E 41.3.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
CRM currently screens at market cap $252.36B and trailing P/E 41.3. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the CRM and REGN stock pages for the full models.
Not investment advice.